One can now pay several thousand euros to have one’s body scanned, one’s blood decoded, one’s biomarkers mapped across two hundred dimensions, one’s cardiovascular risk scored, one’s metabolic trajectory modelled, one’s organ function imaged in high resolution, and one’s results delivered through an application that nudges toward better decisions every day. It is sophisticated. It is beautiful. And it is incomplete in a way that undermines almost everything it promises.

The longevity industry has built the most advanced health dashboard in history. It tracks the hardware with extraordinary precision. And it has almost entirely ignored the operating system.

The microbiome modulates immune function, metabolic response, drug metabolism, inflammatory load, hormonal balance, neurotransmitter production, and the biological pathways through which chronic disease develops over decades. It is not one variable among two hundred. It is the variable that conditions how the other one hundred and ninety-nine express themselves. A biomarker panel without a microbiome assessment is, if I may be direct, a photograph of a building with no knowledge of its foundations. Everything above ground looks measurable, quantifiable, actionable. But the forces determining whether that building stands or falls are underneath, invisible, and unexamined.

This is where the longevity industry currently finds itself. Impressive above ground. Blind below it.

Some clinics have begun to include a breath test. This is presented as microbiome assessment. It is not. A breath test measures the metabolic byproducts of microbial fermentation, typically hydrogen and methane, in response to a substrate. It is useful for detecting small intestinal bacterial overgrowth. It tells you that something is happening. It does not tell you what is happening, who is doing it, or what to do about it. To call a breath test a microbiome assessment is like checking engine temperature and calling it a diagnostic. The temperature tells you the engine is running. It does not tell you which components are failing, which are compensating, which are about to give out, or how the system will respond to the intervention one is planning.

Metagenomic sequencing reads the actual map. It identifies the species present, their relative abundance, their functional capacity, their metabolic potential. It reveals not just that the ecosystem exists but how it is structured, what it can do, and where it is vulnerable. The difference between a breath test and metagenomic sequencing is the difference between hearing a noise in the engine and opening the hood. The longevity industry charges premium prices. It should not be offering a diagnostic equivalent of pressing one’s ear to the bonnet and guessing.

On ne pilote pas un système complexe avec un seul voyant sur le tableau de bord. Surtout quand ce voyant ne mesure que la fumée.

You do not pilot a complex system with a single warning light on the dashboard. Especially when that light only measures the exhaust smoke.

The resistance of this sector to comprehensive microbiome integration is not, I would argue, scientific. The science is mature enough to act upon. The resistance is logistical, commercial, and conceptual. Logistically, stool sampling is less elegant than a blood draw or an MRI. It does not fit the aesthetic of a high-end wellness centre with curated lighting and ambient music. I understand. But medicine is not interior design. Commercially, adding a full microbiome panel increases cost and complexity and introduces results that require a different kind of clinical expertise to interpret. Conceptually, and this is the real barrier, integrating the microbiome means admitting that the existing model is incomplete. It means telling a client who has just paid several thousand euros for a comprehensive assessment that the assessment was not, in fact, comprehensive. That is an uncomfortable conversation. It is also the only honest one.

Because without the microbiome, the longevity dashboard is a sophisticated instrument measuring consequences while ignoring causes. Inflammation shows up in a blood panel. The microbiome is one of the primary systems driving that inflammation. Metabolic dysfunction shows up in glucose and lipid markers. The microbiome is one of the primary systems shaping metabolic response. Immune fragility shows up in functional tests. The microbiome is one of the primary systems training immune competence from birth. One can track these downstream signals with extraordinary precision. One can intervene with supplements, protocols, lifestyle adjustments. But if one never examines the upstream system producing them, one is managing symptoms at altitude. One is optimising the dashboard and ignoring the engine. And one is charging one’s clients handsomely for the privilege of not knowing.

Here is the part that should sting, and I choose the word deliberately. The longevity industry positions itself as the antithesis of reactive medicine. It claims to be predictive, preventive, personalised. And yet it is reproducing the exact structural flaw of the system it claims to replace: treating the body as a collection of measurable parts instead of as an integrated biological ecosystem. A hospital that ignores the microbiome is behind the science. A longevity clinic that ignores it is betraying its own premise.

A truly preventive model would begin with the microbiome, not conclude with a breath test. It would sequence the gut. It would profile the oral microbiome, which is increasingly linked to cardiovascular and neurodegenerative risk. It would track microbial diversity longitudinally, because a single snapshot tells you where the ecosystem is but not where it is heading. It would integrate microbial data with the genomic, metabolic, and inflammatory data it already collects, because the interactions between these layers are where the real predictive power resides. None of this is futuristic. The sequencing technology exists. The analytical frameworks exist. The clinical evidence linking specific microbial signatures to disease trajectories exists. What does not exist is the willingness of this industry to look at what it has been leaving out.

The clients walking into these clinics are the most health-invested, most data-literate, most resource-rich population in the world. They are paying for the most complete picture of their biology available. They deserve to know that the picture has a hole in it. And that the hole is not a minor omission. It is the layer that connects nearly everything else they are measuring.

Longevity without the microbiome is not prevention. It is surveillance. Expensive, elegant, high-resolution surveillance of a system whose most influential variable remains unread.

On peut cartographier tout le corps et rater l’essentiel. Parce que l’essentiel est vivant, changeant, et ne rentre pas encore dans le tableau de bord.

You can map the entire body and miss what matters most. Because what matters most is alive, changing, and does not yet fit on the dashboard.

Et voilà.